Mawer Investment Management Ltd. Grows Position in CME Group Inc (NASDAQ:CME)

Mawer Investment Management Ltd. raised its holdings in shares of CME Group Inc (NASDAQ:CME) by 0.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 694,807 shares of the financial services provider’s stock after purchasing an additional 1,434 shares during the quarter. Mawer Investment Management Ltd.’s holdings in CME Group were worth $134,871,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Close Asset Management Ltd purchased a new stake in CME Group during the first quarter valued at about $34,000. Advantage Investment Management LLC lifted its holdings in CME Group by 119.0% during the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Westside Investment Management Inc. purchased a new stake in CME Group during the second quarter valued at about $38,000. Permanens Capital L.P. purchased a new stake in CME Group during the first quarter valued at about $41,000. Finally, Berman Capital Advisors LLC lifted its holdings in CME Group by 23.9% during the first quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock valued at $56,000 after purchasing an additional 66 shares during the last quarter. 85.72% of the stock is currently owned by institutional investors and hedge funds.

Shares of CME traded down $0.57 during midday trading on Friday, hitting $212.67. 36,644 shares of the company traded hands, compared to its average volume of 1,380,912. The stock has a 50-day moving average of $206.61 and a 200-day moving average of $187.20. CME Group Inc has a one year low of $161.05 and a one year high of $217.65. The firm has a market cap of $76.58 billion, a P/E ratio of 31.15, a PEG ratio of 4.76 and a beta of 0.23. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The company’s revenue was up 20.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.74 earnings per share. Sell-side analysts forecast that CME Group Inc will post 6.68 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.41%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 43.99%.

Several brokerages have recently weighed in on CME. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target on the stock. in a research report on Monday, May 27th. Wells Fargo & Co upped their price target on CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research report on Wednesday, July 3rd. Deutsche Bank upped their price target on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Finally, UBS Group upped their price target on CME Group from $190.00 to $194.00 and gave the company a “neutral” rating in a research report on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the company’s stock. CME Group currently has an average rating of “Hold” and a consensus target price of $194.00.

In related news, insider Kevin Kometer sold 16,140 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $201.19, for a total value of $3,247,206.60. Following the transaction, the insider now directly owns 72,122 shares in the company, valued at $14,510,225.18. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Elizabeth A. Cook sold 300 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $204.27, for a total transaction of $61,281.00. Following the completion of the transaction, the director now owns 20,821 shares in the company, valued at $4,253,105.67. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 76,271 shares of company stock worth $15,290,370. 1.20% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: Technical Analysis

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.